Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Shares Outstanding of 188.31 million shares for fiscal year 2025.
HERON THERAPEUTICS, INC. /DE/ Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 188.31M | +23.8% |
| 2024 | 152.13M | +1.2% |
| 2023 | 150.29M | +26.1% |
| 2022 | 119.15M | +16.8% |
| 2021 | 102.00M | +11.7% |
| 2020 | 91.31M | +1.1% |
| 2019 | 90.30M | +15.5% |
| 2018 | 78.17M | +21.0% |
| 2017 | 64.61M | +164069.7% |
| 2016 | 39,355 | -99.9% |
| 2015 | 36.11M | +23.5% |
| 2014 | 29.23M | +24.0% |
| 2013 | 23.57M | +56.0% |
| 2012 | 15.11M | -92.4% |
| 2011 | 200.05M | +398.3% |
| 2010 | 40.14M | — |
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +23.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, HERON THERAPEUTICS, INC. /DE/’s shares outstanding has grown by 369.1% (from 40.14 million shares to 188.31 million shares).
- The most recent figure is from HERON THERAPEUTICS, INC. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: